000144414 001__ 144414
000144414 005__ 20240229112623.0
000144414 0247_ $$2doi$$a10.1093/jrr/rrz048
000144414 0247_ $$2pmid$$apmid:31322705
000144414 0247_ $$2ISSN$$a0449-3060
000144414 0247_ $$2ISSN$$a1349-9157
000144414 0247_ $$2altmetric$$aaltmetric:63807275
000144414 037__ $$aDKFZ-2019-01867
000144414 041__ $$aeng
000144414 082__ $$a610
000144414 1001_ $$0P:(DE-HGF)0$$aArians, Nathalie$$b0$$eFirst author
000144414 245__ $$aCarbon-ion irradiation overcomes HPV-integration/E2 gene-disruption induced radioresistance of cervical keratinocytes.
000144414 260__ $$aKawaguchi$$bJ-STAGE$$c2019
000144414 3367_ $$2DRIVER$$aarticle
000144414 3367_ $$2DataCite$$aOutput Types/Journal article
000144414 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1675087544_25376
000144414 3367_ $$2BibTeX$$aARTICLE
000144414 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000144414 3367_ $$00$$2EndNote$$aJournal Article
000144414 500__ $$aJ Radiat Res. 2019 Oct 23;60(5):564-572
000144414 520__ $$aTo date, only few data exist on mechanisms underlying the human papillomavirus (HPV)-associated irradiation response. It has been suggested, that the viral E2 gene plays an important role in that context. The aim of the current study is to compare the effect of photon- and carbon-ion (12C)-radiation therapy (RT) on cells with different HPV and E2 gene status. We hypothesized that 12C-RT might overcome the radioresistance of E2 gene-disrupted cells. We analyzed four different cell lines that differed in HPV status or E2 gene status. Cells were irradiated with either photons or 12C. Clonogenic survival, cell cycle and expression of Rb and p53 were analyzed. Radiosensitivity seemed to be dependent on E2 gene status and type of RT. 12C-RT led to lower surviving fractions, indicating higher radiosensitivity even in cells with disrupted E2 gene. The observed relative biological effectiveness (RBE) of 12C-RT for C33a/Caski and W12/S12 was 1.3/4 and 2.7/2.5, respectively. Cell cycle regulation after both photon- and 12C-RT was dependent on HPV status and on E2 gene status. Furthermore, the effect of RT on expression of p53 and Rb seemed to be dependent on E2 gene status and type of RT. We showed that 12C-RT overcomes HPV-integration induced radioresistance. The effect of RT on cell cycle regulation as well as on expression of p53 and Rb seemed to be dependent on HPV status, E2 gene status and type of RT. Differences in Rb expression and cell cycle regulation may play a role for enhanced radiosensitivity to 12C-RT of cells with disrupted E2 gene.
000144414 536__ $$0G:(DE-HGF)POF3-315$$a315 - Imaging and radiooncology (POF3-315)$$cPOF3-315$$fPOF III$$x0
000144414 588__ $$aDataset connected to CrossRef, PubMed,
000144414 7001_ $$0P:(DE-He78)8d52e7ff1ccaac7dbf0232fdcb0168bd$$aNicolay, Nils Henrik$$b1$$udkfz
000144414 7001_ $$aBrons, Stephan$$b2
000144414 7001_ $$aKoerber, Stefan Alexander$$b3
000144414 7001_ $$aJaschke, Christine$$b4
000144414 7001_ $$aVercruysse, Marco$$b5
000144414 7001_ $$aDaffinger, Sigrid$$b6
000144414 7001_ $$0P:(DE-He78)80e100a16534f5fc67f7436ee67a47f9$$aRühle, Alexander$$b7$$udkfz
000144414 7001_ $$0P:(DE-He78)8714da4e45acfa36ce87c291443a9218$$aDebus, Jürgen$$b8$$udkfz
000144414 7001_ $$aLindel, Katja$$b9
000144414 773__ $$0PERI:(DE-600)2038914-0$$a10.1093/jrr/rrz048$$gp. rrz048$$n5$$p564-572$$tJournal of radiation research$$v60$$x1349-9157$$y2019
000144414 909CO $$ooai:inrepo02.dkfz.de:144414$$pVDB
000144414 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000144414 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)8d52e7ff1ccaac7dbf0232fdcb0168bd$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000144414 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)80e100a16534f5fc67f7436ee67a47f9$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000144414 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)8714da4e45acfa36ce87c291443a9218$$aDeutsches Krebsforschungszentrum$$b8$$kDKFZ
000144414 9131_ $$0G:(DE-HGF)POF3-315$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vImaging and radiooncology$$x0
000144414 9141_ $$y2019
000144414 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000144414 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000144414 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central
000144414 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal
000144414 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ
000144414 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Double blind peer review
000144414 915__ $$0LIC:(DE-HGF)CCBYNCNV$$2V:(DE-HGF)$$aCreative Commons Attribution-NonCommercial CC BY-NC (No Version)$$bDOAJ
000144414 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ RADIAT RES : 2017
000144414 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000144414 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000144414 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000144414 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000144414 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000144414 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000144414 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000144414 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000144414 9201_ $$0I:(DE-He78)E050-20160331$$kE050$$lE050 KKE Strahlentherapie$$x0
000144414 9201_ $$0I:(DE-He78)L101-20160331$$kL101$$lDKTK Heidelberg$$x1
000144414 9201_ $$0I:(DE-He78)E055-20160331$$kE055$$lE055 KKE Molekulare Radioonkologie$$x2
000144414 980__ $$ajournal
000144414 980__ $$aVDB
000144414 980__ $$aI:(DE-He78)E050-20160331
000144414 980__ $$aI:(DE-He78)L101-20160331
000144414 980__ $$aI:(DE-He78)E055-20160331
000144414 980__ $$aUNRESTRICTED